Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health (TDOC) delivers whole-person virtual care through AI-driven solutions and integrated digital health services. This news hub provides investors and healthcare professionals with essential updates on the company's strategic initiatives, operational milestones, and market developments.
Access real-time information about earnings announcements, technology partnerships, clinical research breakthroughs, and regulatory updates. Our curated collection features official press releases alongside third-party analysis of TDOC's expanding telehealth capabilities and chronic care management innovations.
Key updates include:
• Quarterly financial results
• Strategic acquisitions
• Clinical study outcomes
• Platform enhancements
• Leadership appointments
Bookmark this page for streamlined tracking of Teladoc Health's progress in transforming healthcare delivery through virtual-first solutions. Combine these updates with our comprehensive company profile for informed decision-making in the evolving digital health sector.
Teladoc Health (TDOC) reported first quarter 2023 revenue of $629.2 million, reflecting an 11% year-over-year growth. However, the company posted a net loss of $69.2 million or ($0.42) per share, compared to a substantial loss of $6.67 billion in Q1 2022, which was mainly due to a prior goodwill impairment. Adjusted EBITDA decreased by 3% to $52.8 million. The Integrated Care segment saw revenue growth of 5% to $350 million, while BetterHelp revenue surged 21% to $279.3 million. Looking ahead, Teladoc projects Q2 2023 revenue of $635 - $660 million and expects a full year 2023 revenue between $2.575 - $2.675 billion. The financial outlook indicates potential improvement despite ongoing losses.
FAQ
What is the current stock price of Teladoc Health (TDOC)?
What is the market cap of Teladoc Health (TDOC)?
